Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor
go back to main search page
Accession:CHEBI:67232 term browser browse the term
Definition:An EC 3.2.1.* (glycosidase) inhibitor that inhibits the action of sucrose oligo-1,6-glucosidase (EC 3.2.1.10).
Synonyms:related_synonym: EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitors;   EC 3.2.1.10 inhibitor;   EC 3.2.1.10 inhibitors;   alpha-limit dextrinase inhibitor;   alpha-limit dextrinase inhibitors;   dextrin 6-glucanohydrolase inhibitor;   dextrin 6-glucanohydrolase inhibitors;   dextrin 6alpha-glucanohydrolase inhibitor;   dextrin 6alpha-glucanohydrolase inhibitors;   exo-oligo-1,6-glucosidase inhibitor;   exo-oligo-1,6-glucosidase inhibitors;   isomaltase inhibitor;   isomaltase inhibitors;   oligo-1,6-glucosidase inhibitor;   oligo-1,6-glucosidase inhibitors;   oligosaccharide alpha-1,6-glucohydrolase inhibitor;   oligosaccharide alpha-1,6-glucohydrolase inhibitors;   sucrase-isomaltase inhibitor;   sucrase-isomaltase inhibitors


show annotations for term's descendants       view all columns           Sort by:
 
conduritol B epoxide term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Gba glucosylceramidase beta JBrowse link 2 188,511,781 188,522,602 RGD:6480464
G Snca synuclein alpha JBrowse link 4 90,782,412 90,883,236 RGD:6480464

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19779
    role 19727
      biological role 19726
        biochemical role 19220
          enzyme inhibitor 18097
            EC 3.* (hydrolase) inhibitor 17584
              EC 3.2.* (glycosylase) inhibitor 5069
                EC 3.2.1.* (glycosidase) inhibitor 5069
                  EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor 2
                    1-D-1,2-anhydro-myo-inositol + 2
                    3-epi-fagomine 0
                    conduritol B epoxide 2
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.